T
Trilok Shrivastava
Assistant Professor
faculty
COM | Internal Med Hem-Onc
4 h-index
49 pubs
72 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Trilok Shrivastava's research focuses on hematologic malignancies, particularly multiple myeloma. His recent publications investigate therapeutic targets such as B cell maturation antigen in multiple myeloma, the psychological impact of precursor conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, and the management of central nervous system involvement in multiple myeloma. He also contributes to broader clinical research through a meta-analysis on thromboprophylaxis in COVID-19 patients. Shrivastava has published 48 works with 70 citations and an h-index of 4. He actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Ramya Bachu and Tanvi H Patel, with whom he shares multiple publications.
Metrics
- h-index: 4
- Publications: 49
- Citations: 72
Selected Publications
-
Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma (2025)
-
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
-
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2024)
-
Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. (2024)
-
A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma (2024)
-
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2023)
-
Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023)
-
Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives (2023)
Collaboration Network
Top Collaborators
Binav Baral
John H. Stroger, Jr. Hospital of Cook County (US)
12 shared publications
- Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
- Survival outcomes of primary mediastinal germ cell malignancies based on clinicopathological characteristics: A SEER database analysis.
- Sixty-day unplanned readmissions after robot-assisted versus open-radical prostatectomy.
- Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
- Impact and predictors of readmission in hypercalcemia of malignancy: Findings of a nationwide analysis.
Showing 5 of 12 shared publications
Miguel Salazar
Cleveland Clinic (US)
7 shared publications
- Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
- Impact and predictors of readmission in hypercalcemia of malignancy: Findings of a nationwide analysis.
- Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis.
- In-hospital outcomes of transcatheter aortic valve replacement (TAVR) in patients with localized and metastatic malignancy.
- Predictors of 30-day readmission rate after liver transplant in patients with hepatocellular carcinoma.
Showing 5 of 7 shared publications
Estefania Gauto
John H. Stroger, Jr. Hospital of Cook County (US)
7 shared publications
- Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
- Impact and predictors of readmission in hypercalcemia of malignancy: Findings of a nationwide analysis.
- Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis.
- In-hospital outcomes of transcatheter aortic valve replacement (TAVR) in patients with localized and metastatic malignancy.
- Predictors of 30-day readmission rate after liver transplant in patients with hepatocellular carcinoma.
Showing 5 of 7 shared publications
Samer Al Hadidi
Winthrop Rockefeller Foundation
7 shared publications
In database
- Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
Showing 5 of 7 shared publications
Ramya Bachu
University of Arkansas for Medical Sciences
7 shared publications
In database
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
Showing 5 of 7 shared publications
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
7 shared publications
In database
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
Showing 5 of 7 shared publications
Frits van Rhee
Winthrop Rockefeller Foundation
6 shared publications
In database
- Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
Showing 5 of 6 shared publications
Carolina Schinke
Winthrop Rockefeller Foundation
6 shared publications
In database
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Showing 5 of 6 shared publications
Maurizio Zangari
University of Arkansas for Medical Sciences
6 shared publications
In database
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
- Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma.
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Showing 5 of 6 shared publications
Prasanth Lingamaneni
John H. Stroger, Jr. Hospital of Cook County (US)
5 shared publications
- Survival outcomes of primary mediastinal germ cell malignancies based on clinicopathological characteristics: A SEER database analysis.
- Long-term time trends in incidence, survival, and mortality of malignant melanoma in the United States.
- Sixty-day unplanned readmissions after robot-assisted versus open-radical prostatectomy.
- A nationwide analysis of healthcare utilization and outcomes of sepsis in HIV versus non-HIV patients with Hodgkin lymphoma.
- Health care utilization and outcomes of sepsis in HIV versus non-HIV patients with Burkitt Lymphoma: A nationwide analysis.
Kriti Ahuja
John H. Stroger, Jr. Hospital of Cook County (US)
4 shared publications
- A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia
- Long-term time trends in incidence, survival, and mortality of malignant melanoma in the United States.
- Development of breast cancer after thyroid cancer and trends over time.
- Hypercalcemia as a predictor of adverse treatment outcomes in DLBCL during chemotherapy: A national inpatient database study.
Shweta Gupta
John H. Stroger, Jr. Hospital of Cook County (US)
4 shared publications
- Development of breast cancer after thyroid cancer and trends over time.
- Sixty-day unplanned readmissions after robot-assisted versus open-radical prostatectomy.
- A nationwide analysis of healthcare utilization and outcomes of sepsis in HIV versus non-HIV patients with Hodgkin lymphoma.
- Health care utilization and outcomes of sepsis in HIV versus non-HIV patients with Burkitt Lymphoma: A nationwide analysis.
Shristi Upadhyay Banskota
John H. Stroger, Jr. Hospital of Cook County (US)
4 shared publications
- Survival outcomes of primary mediastinal germ cell malignancies based on clinicopathological characteristics: A SEER database analysis.
- Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
- In-hospital outcomes of transcatheter aortic valve replacement (TAVR) in patients with localized and metastatic malignancy.
- Predictors of 30-day readmission rate after liver transplant in patients with hepatocellular carcinoma.
Maha AT Elsebaie
John H. Stroger, Jr. Hospital of Cook County (US)
4 shared publications
- Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
- Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
- Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis.
- Hypercalcemia as a predictor of adverse treatment outcomes in DLBCL during chemotherapy: A national inpatient database study.
Shristi Upadhyay
John H. Stroger, Jr. Hospital of Cook County (US)
4 shared publications
- Impact and predictors of readmission in hypercalcemia of malignancy: Findings of a nationwide analysis.
- Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis.
- Risk factors for 30-day readmissions in patients with tumor lysis syndrome and solid malignancies: Analysis from the National Readmission Database.
- Thirty-day readmission after percutaneous coronary intervention with drug eluting stent in patients with active malignancy.
Similar Researchers
Based on overlapping research topics
Naveen Yarlagadda
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Farah Mazahreh
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Liyan Mazahreh
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Abdul Rafae
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Abdul Rafae
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Hira Imad Cheema
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews